Stifel Financial
NKTR icon

Stifel Financial’s Nektar Therapeutics NKTR Stock Holding History

Stifel Financial’s Portfolio NKTR Stock Details NKTR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-690
Closed -$369K – 2937
2019
Q2 		$369K Buy
690
+12
+2% +$6.02K ﹤0.01% 2374
2019
Q1 		$341K Buy
678
+163
+32% +$96.6K ﹤0.01% 2286
2018
Q4 		$253K Sell
515
-396
-43% -$239K ﹤0.01% 2325
2018
Q3 		$833K Sell
911
-9
-1% -$7.68K ﹤0.01% 1795
2018
Q2 		$674K Sell
920
-156
-14% -$180K ﹤0.01% 1864
2018
Q1 		$1.72M Sell
1,076
-635
-37% -$818K 0.01% 1244
2017
Q4 		$1.53M Sell
1,711
-66
-4% -$39K ﹤0.01% 1286
2017
Q3 		$640K Sell
1,777
-3
-0.2% -$938 ﹤0.01% 1741
2017
Q2 		$523K Sell
1,780
-161
-8% -$46.5K ﹤0.01% 1844
2017
Q1 		$684K Buy
1,941
+209
+12% +$47K ﹤0.01% 1642
2016
Q4 		$319K Buy
+1,732
New +$352K ﹤0.01% 2009
2016
Q1 		– Sell
-797
Closed -$201K – 2336
2015
Q4 		$201K Buy
+797
New +$164K ﹤0.01% 2113
2015
Q3 		– Sell
-1,100
Closed -$207K – 2326
2015
Q2 		$207K Sell
1,100
-80
-7% -$13.8K ﹤0.01% 2152
2015
Q1 		$194K Hold
1,180
– – ﹤0.01% 2125
2014
Q4 		$274K Buy
1,180
+360
+44% +$76.9K ﹤0.01% 1924
2014
Q3 		$148K Sell
820
-8
-1% -$1.53K ﹤0.01% 2062
2014
Q2 		$160K Buy
828
+7
+0.9% +$1.24K ﹤0.01% 2046
2014
Q1 		$150K Buy
+821
New +$162K ﹤0.01% 1964

Other funds holding NKTR

Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Stifel Financial's NKTR Position: Q3 2019 in Review

Stifel Financial sold out of Nektar Therapeutics (NKTR) in Q3 2019, closing a stake of 690 shares — an estimated $369K sold.

Stifel Financial first reported a position in NKTR in Q1 2014 and held it in 18 quarters. The position peaked at $1.72M in Q1 2018. 287 funds tracked by Wall St. Rank hold NKTR as of Q3 2019.

  • Stifel Financial reported no remaining Nektar Therapeutics position as of Q3 2019 after selling out during the quarter.
  • Stifel Financial sold 690 Nektar Therapeutics shares in Q3 2019, an estimated $369K.
  • Stifel Financial first reported a position in Nektar Therapeutics in Q1 2014 and held it in 18 quarters.
  • Stifel Financial's Nektar Therapeutics position peaked at $1.72M in Q1 2018.
  • 287 funds tracked by Wall St. Rank held Nektar Therapeutics as of Q3 2019.

Based on Stifel Financial's 13F filing for Q3 2019, filed 13 Nov 2019.